|Videos|November 26, 2017

What Are Some Causes of Persisting Symptoms After Lyme Disease Infection?

Leonard Sigal, MD, discusses different causes of persisting symptoms after Lyme disease infection.

Leonard Sigal, MD, clinical professor and former chief of the Division of Rheumatology at Robert Wood Johnson UMDNJ Medical School, discusses different causes of persisting symptoms after Lyme disease infection.

Interview Transcript (modified slightly for readability):

“Some patients with Lyme disease who are treated will have ongoing symptoms that don’t resolve or resolve very slowly. And so, for the latter group, you just have to wait; it’s called tincture of time. Just wait, and as long as they’re not getting worse, as long as they’re not showing new symptoms, if things are beginning to quiet down, then you can say to yourself, ‘Okay, this is the course that Lyme disease sometimes follows; we just wait.

If a person, after having antibiotic therapy, develops new manifestations in what you think is Lyme disease, then you have to either assume that they have been re-infected, which is sort of unlikely—not impossible—but unlikely, or what you gave them was insufficient. And then what you do is go back and retreat. Then, the question, of course, is are you treating ongoing Lyme disease, Borrelia burgdorferi infection, or are you treating something else entirely? And that is up to the clinician to decide.”


Related to this article

Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
FAQ: What You Need to Know About West Nile Virus in 2026
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.